Literature DB >> 15893112

Are vasoactive neuropeptide autoimmune fatigue-related disorders mediated via G protein-coupled receptors?

Donald Staines1.   

Abstract

Vasoactive neuropeptides such as pituitary adenylate cyclase activating polypeptide (PACAP), calcitonin gene related peptide (CGRP) and vasoactive intestinal peptide (VIP) have been implicated in a number of fatigue-related conditions. Associations of these vasoactive neuropeptides with heat shock proteins (hsps) and cytosine-guanosine dinucleotide (CpG) DNA fragments in autoimmune phenomena have been postulated to interfere with receptor signal activation for adenylate cyclase and other vital cellular processes. However, a specific mechanism for receptor dysfunction has not been explored to date. G protein-coupled receptors (GPCRs) constitute a high proportion of biological receptor mechanisms and serve a wide range of substances including nucleosides, nucleotides, catecholamines, calcium, histamine, serotonin and prostaglandins. They are complex transmembrane hepta-helical serpentine structures with specific binding capabilities resulting in conformational changes that activate cognate cyclic GMP (G proteins). GPCRs adapt to certain stimuli through desensitisation and changes in phosphorylation and are subject to distortions of signalling processes. Hence, these vital signalling structures are susceptible to impairment of function through a range of mechanisms. One of their vital functions is signalling through adenylate cyclase, a vital step in cyclic AMP metabolism. This step involves ATP metabolism and therefore is a crucial mediator of cellular energy pathways. Some GPCRs act to inhibit adenylate cyclase (Gi proteins). Also vasoactive neuropeptides, such as PACAP display a number of receptor isotypes including null variants. Overexpression of Gi proteins and null variant receptors may account for major disruptions of signal transduction and ATP/cAMP metabolism. This paper examines the possible role of GPCR dysfunction in contributing to fatigue-related vasoactive neuropeptide autoimmune disorders which may include chronic fatigue syndrome (CFS), Gulf War syndrome (GWS) and even sudden infant death syndrome (SIDS).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893112     DOI: 10.1016/j.mehy.2005.02.013

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

1.  Associations Between Neurotransmitter Genes and Fatigue and Energy Levels in Women After Breast Cancer Surgery.

Authors:  Jasmine Eshragh; Anand Dhruva; Steven M Paul; Bruce A Cooper; Judy Mastick; Deborah Hamolsky; Jon D Levine; Christine Miaskowski; Kord M Kober
Journal:  J Pain Symptom Manage       Date:  2016-10-05       Impact factor: 3.612

2.  Endogenous inhibition of the trigeminally evoked neurotransmission to cardiac vagal neurons by muscarinic acetylcholine receptors.

Authors:  C Gorini; K Philbin; R Bateman; D Mendelowitz
Journal:  J Neurophysiol       Date:  2010-08-18       Impact factor: 2.714

3.  Meta analysis of Chronic Fatigue Syndrome through integration of clinical, gene expression, SNP and proteomic data.

Authors:  Vasyl Pihur; Somnath Datta; Susmita Datta
Journal:  Bioinformation       Date:  2011-04-22

4.  A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome.

Authors:  Katherine James; Shereen Al-Ali; Jessica Tarn; Simon J Cockell; Colin S Gillespie; Victoria Hindmarsh; James Locke; Sheryl Mitchell; Dennis Lendrem; Simon Bowman; Elizabeth Price; Colin T Pease; Paul Emery; Peter Lanyon; John A Hunter; Monica Gupta; Michele Bombardieri; Nurhan Sutcliffe; Costantino Pitzalis; John McLaren; Annie Cooper; Marian Regan; Ian Giles; David Isenberg; Vadivelu Saravanan; David Coady; Bhaskar Dasgupta; Neil McHugh; Steven Young-Min; Robert Moots; Nagui Gendi; Mohammed Akil; Bridget Griffiths; Anil Wipat; Julia Newton; David E Jones; John Isaacs; Jennifer Hallinan; Wan-Fai Ng
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

5.  Does autoimmunity of endogenous vasoactive neuropeptides cause retinopathy in humans?

Authors:  Donald R Staines
Journal:  Med Hypotheses       Date:  2007-06-07       Impact factor: 1.538

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.